Breaking News

Has no content to show!

In the 2000s, India’s efforts in reducing poverty bore fruits: the percentage of people below the international poverty line dropped from 38.9% to 21.2%, as per the World Bank.

Indian automobile industry is on the rise and in the month of May 2018, the overall industry sold a total of 22.82 lakh units selling almost 73,632 units every day.

Nirav Modi, the billionaire jeweller at the heart of a more than $2 billion fraud case in India, has fled to the UK, where he is claiming political asylum, the Financial Times reported on Sunday, citing Indian and British officials.

A cryptocurrency exchange hack in South Korea jolted holders of digital assets, fueling a $46 billion rout and extending this year’s Bitcoin slump to more than 50 percent.

Shares of Avanti Feeds have rallied 8% to Rs 1,980 per share, extending their over 30% surge in past three trading sessions on the BSE, after the company announced stock split from Rs 2 to Re 1 and issue of bonus shares in the ratio of 1:2.

As multi-agency probe continues in India into alleged lapses involving ICICI Bank’s chief Chanda Kochhar (pictured) and her family members, the matter has also come under the scanner of the US markets regulator Securities and Exchange Commission (SEC).

Markets are trading higher today, on a mix of trade tensions ahead of a landmark meeting between US President Donald Trump and North Korean leader Kim Jong Un scheduled tomorrow.

Shares of Cipla rose nearly 3 percent intraday Friday as company partnered with Eli Lilly for the marketing and distribution of Lilly’s BASAGLAR in India.

Aurobindo Pharma said it has received final approval from the US health regulator to manufacture Omeprazole delayed-release tablets, used in the treatment of frequent heartburn.

Friday, 08 June 2018 15:44

Sun Pharma gets VAI at Halol facility

The wait for the investors of Sun Pharma is finally over with the Halol plant getting a clearance. This facility has received a Voluntary Action Indicated (VAI) status from the US drug regulator.

Page 6 of 753

About Us

Wealthbuilder.co.in is design and developed to provide quality trading and investment recommendations & guidance for trading in the Indian Stock Market.

Wealthbuilder.co.in attempts to deliver a value driven service to the investing community by bringing together a powerful mix of expert advice, stock news and analysis.

Contact Information


Brand Partners